共 7 条
[1]
Effects of ramipril on cardiovascular and microvascular outcomes in peoples with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. HEART OUTCOMES PREVENTION EVALUATION (HOPE) STUDY INVESTIGATORS. The Lancet . 2000
[2]
Treatment of hypertension in adults with diabetes. AMERICAN DIABETES ASSOCIATION. Clinical Diabetes . 2003
[3]
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. THE HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS. The New England Journal of Medicine . 2000
[4]
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus: atherosclerosis risk in communities study. GRESS T W,NIETO F J,SHAHAR E,et al. The New England Journal of Medicine . 2000
[5]
Diabetes, hypertension,and cardiovascular disease. SOWERS J R,EPSTEIN M,FROHLICH E D. Journal of Hypertension . 2001
[6]
Effect of angiotensin- converting - enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project ( CAPPP) randomised trial. HANSSON L,LINDHOLM L H,NISKANEN L,et al. The Lancet . 1999
[7]
The diabetes prevention program and its global implications. MOLITCH M E,FUJIMOTO W,HAMMAN R F,et al. Journal of the American Society of Nephrology . 2003